133 related articles for article (PubMed ID: 10546705)
1. Seroprevalence of human papillomavirus type 16 in pregnant women.
Hagensee ME; Slavinsky J; Gaffga CM; Suros J; Kissinger P; Martin DH
Obstet Gynecol; 1999 Nov; 94(5 Pt 1):653-8. PubMed ID: 10546705
[TBL] [Abstract][Full Text] [Related]
2. Correlates of the spread of human papillomavirus infection.
Silins I; Kallings I; Dillner J
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):953-9. PubMed ID: 11008914
[TBL] [Abstract][Full Text] [Related]
3. Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA.
Olsen AO; Dillner J; Gjøen K; Magnus P
Genitourin Med; 1997 Apr; 73(2):131-5. PubMed ID: 9215097
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence.
Kreimer AR; Alberg AJ; Viscidi R; Gillison ML
Sex Transm Dis; 2004 Apr; 31(4):247-56. PubMed ID: 15028941
[TBL] [Abstract][Full Text] [Related]
5. Incidence, clearance and predictors of human papillomavirus infection in women.
Sellors JW; Karwalajtys TL; Kaczorowski J; Mahony JB; Lytwyn A; Chong S; Sparrow J; Lorincz A;
CMAJ; 2003 Feb; 168(4):421-5. PubMed ID: 12591782
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes.
Touzé A; de Sanjosé S; Coursaget P; Almirall MR; Palacio V; Meijer CJ; Kornegay J; Bosch FX
J Clin Microbiol; 2001 Dec; 39(12):4344-8. PubMed ID: 11724843
[TBL] [Abstract][Full Text] [Related]
7. High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico.
Hernández-Girón C; Smith JS; Lorincz A; Lazcano E; Hernández-Avila M; Salmerón J
Sex Transm Dis; 2005 Oct; 32(10):613-8. PubMed ID: 16205302
[TBL] [Abstract][Full Text] [Related]
8. A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children.
af Geijersstam V; Eklund C; Wang Z; Sapp M; Schiller JT; Dillner J; Dillner L
Int J Cancer; 1999 Feb; 80(4):489-93. PubMed ID: 9935145
[TBL] [Abstract][Full Text] [Related]
9. Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity.
Castle PE; Shields T; Kirnbauer R; Manos MM; Burk RD; Glass AG; Scott DR; Sherman ME; Schiffman M
Sex Transm Dis; 2002 Mar; 29(3):182-7. PubMed ID: 11875380
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women.
Viscidi RP; Kotloff KL; Clayman B; Russ K; Shapiro S; Shah KV
Clin Diagn Lab Immunol; 1997 Mar; 4(2):122-6. PubMed ID: 9067643
[TBL] [Abstract][Full Text] [Related]
11. HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates.
Strickler HD; Kirk GD; Figueroa JP; Ward E; Braithwaite AR; Escoffery C; Drummond J; Goebel B; Waters D; McClimens R; Manns A
Int J Cancer; 1999 Jan; 80(3):339-44. PubMed ID: 9935171
[TBL] [Abstract][Full Text] [Related]
12. Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989.
af Geijersstam V; Wang Z; Lewensohn-Fuchs I; Eklund C; Schiller JT; Forsgren M; Dillner J
Int J Cancer; 1998 May; 76(3):341-4. PubMed ID: 9579570
[TBL] [Abstract][Full Text] [Related]
13. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland.
Laukkanen P; Koskela P; Pukkala E; Dillner J; Läärä E; Knekt P; Lehtinen M
J Gen Virol; 2003 Aug; 84(Pt 8):2105-2109. PubMed ID: 12867641
[TBL] [Abstract][Full Text] [Related]
14. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.
Thompson DL; Douglas JM; Foster M; Hagensee ME; Diguiseppi C; Barón AE; Cameron JE; Spencer TC; Zenilman J; Malotte CK; Bolan G; Kamb ML; Peterman TA;
J Infect Dis; 2004 Nov; 190(9):1563-74. PubMed ID: 15478060
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study.
Hildesheim A; Han CL; Brinton LA; Kurman RJ; Schiller JT
Obstet Gynecol; 1997 Nov; 90(5):748-54. PubMed ID: 9351758
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of human papillomavirus infection in pregnant versus non-pregnant women in Brazil.
Salcedo MM; Damin AP; Agnes G; Pessini SA; Beitune PE; Alexandre CO; Schmeler KM; da Silveira GP
Arch Gynecol Obstet; 2015 Dec; 292(6):1273-8. PubMed ID: 25990479
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of 10 human papillomavirus types in the general rural population of Anyang, China: a cross-sectional study.
Zhang C; Liu F; Deng Q; He Z; Xi L; Liu Y; Pan Y; Ning T; Guo C; Xu R; Zhang L; Cai H; Ke Y
Sex Transm Infect; 2015 Nov; 91(7):506-9. PubMed ID: 25999521
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of human papillomavirus infections in term pregnancy.
Peng TC; Searle CP; Shah KV; Repke JT; Johnson TR
Am J Perinatol; 1990 Apr; 7(2):189-92. PubMed ID: 2158782
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
Carter JJ; Madeleine MM; Shera K; Schwartz SM; Cushing-Haugen KL; Wipf GC; Porter P; Daling JR; McDougall JK; Galloway DA
Cancer Res; 2001 Mar; 61(5):1934-40. PubMed ID: 11280749
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy and cervical infection with human papillomaviruses.
Morrison EA; Gammon MD; Goldberg GL; Vermund SH; Burk RD
Int J Gynaecol Obstet; 1996 Aug; 54(2):125-30. PubMed ID: 9236309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
